NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership5,119,838 shares
Latest Disclosed Value $ 37,989,198
State Street Corp reports 2.84% increase in ownership of NEO / NeoGenomics, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 5,119,838 shares of NeoGenomics, Inc. (US:NEO) valued at $37,989,198 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,978,292 shares of NeoGenomics, Inc.. This represents a change in shares of 2.84% during the quarter. The current value of the position is $57,905,368 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEOGENOMICS COM NEW 64049M209 5,119,838 141,546 2.84 37,989 -35.11 0.0013
2026-02-13 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 4,978,292 -43,959 -0.88 58,545 51.00 0.0020
2025-11-14 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 5,022,251 -88,883 -1.74 38,772 3.77 0.0013
2025-08-14 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 5,111,134 21,767 0.43 37,362 -22.64 0.0014
2025-05-15 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 5,089,367 -109,120 -2.10 48,298 -43.62 0.0020
2025-02-14 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 5,198,487 239,905 4.84 85,671 17.13 0.0034
2024-11-14 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 4,958,582 80,449 1.65 73,139 8.10 0.0030
2024-08-14 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 4,878,133 -19,633 -0.40 67,660 -12.12 0.0030
2024-05-15 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 4,897,766 52,821 1.09 76,993 -1.78 0.0034
2024-02-14 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 4,844,945 -79,544 -1.62 78,391 29.42 0.0038
2023-11-14 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 4,924,489 -1,903 -0.04 60,571 -23.49 0.0034
2023-08-14 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 4,926,392 40,222 0.82 79,167 -6.94 0.0042
2023-05-15 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 4,886,170 236,236 5.08 85,069 98.00 0.0048
2023-05-15 2022-12-31 13F/A-99 NEOGENOMICS COM NEW 64049M209 4,649,934 432,774 10.26 42,965 18.33 0.0025
2023-05-15 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 4,649,934 432,774 42,965 0.0025
2022-11-15 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 4,217,160 116,802 2.85 36,310 8.65 0.0023
2022-08-15 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 4,100,358 141,195 3.57 33,418 -30.53 0.0020
2022-05-16 2022-03-31 13F NEOGENOMICS COM NEW 64049M209 3,959,163 150,466 3.95 48,104 -62.98 0.0024
2022-02-14 2021-12-31 13F NEOGENOMICS COM NEW 64049M209 3,808,697 227,955 6.37 129,953 -24.77 0.0062
2021-11-15 2021-09-30 13F NEOGENOMICS COM NEW 64049M209 3,580,742 91,271 2.62 172,735 9.59 0.0091
2021-08-16 2021-06-30 13F NEOGENOMICS COM NEW 64049M209 3,489,471 190,095 5.76 157,619 -0.95 0.0083
2021-07-09 2021-03-31 13F/A-1 NEOGENOMICS COM NEW 64049M209 3,299,376 143,480 4.55 159,129 -6.35 0.0091
2021-05-17 2021-03-31 13F NEOGENOMICS COM NEW 64049M209 3,299,376 143,480 159,129 0.0091
2021-02-16 2020-12-31 13F NEOGENOMICS COM NEW 64049M209 3,155,896 18,882 0.60 169,913 46.83 0.0104
2020-11-10 2020-09-30 13F NEOGENOMICS COM NEW 64049M209 3,137,014 -74,679 -2.33 115,724 16.31 0.0079
2020-08-14 2020-06-30 13F NEOGENOMICS COM NEW 64049M209 3,211,693 204,087 6.79 99,498 19.82 0.0072
2020-06-19 2020-03-31 13F/A-1 NEOGENOMICS COM NEW 64049M209 3,007,606 236,659 8.54 83,040 2.46 0.0073
2020-05-11 2020-03-31 13F NEOGENOMICS COM NEW 64049M209 3,007,606 236,659 83,040 7,292.5840
2020-02-06 2019-12-31 13F NEOGENOMICS COM NEW 64049M209 2,770,947 69,457 2.57 81,050 56.92 0.0056
2019-11-14 2019-09-30 13F NEOGENOMICS COM NEW 64049M209 2,701,490 126,750 4.92 51,652 -8.56 0.0038
2019-08-14 2019-06-30 13F NEOGENOMICS COM NEW 64049M209 2,574,740 227,765 9.70 56,490 17.64 0.0042
2019-05-15 2019-03-31 13F NEOGENOMICS COM NEW 64049M209 2,346,975 1,100,134 88.23 48,019 205.41 0.0037
2019-02-12 2018-12-31 13F NEOGENOMICS COM NEW 64049M209 1,246,841 54,629 4.58 15,723 -14.08 0.0014
2018-11-09 2018-09-30 13F NEOGENOMICS Common equity shares 64049M209 1,192,212 96,966 8.85 18,300 27.46 0.0014
2018-08-14 2018-06-30 13F NEOGENOMICS Common equity shares 64049M209 1,095,246 -1,414 -0.13 14,357 60.43 0.0012
2018-05-15 2018-03-31 13F NEOGENOMICS Common equity shares 64049M209 1,096,660 9,341 0.86 8,949 -7.10 0.0008
2018-02-14 2017-12-31 13F NEOGENOMICS Common equity shares 64049M209 1,087,319 53,842 5.21 9,633 -16.26 0.0008
2017-11-14 2017-09-30 13F NEOGENOMICS Common equity shares 64049M209 1,033,477 34,465 3.45 11,503 28.48 0.0010
2017-08-14 2017-06-30 13F NEOGENOMICS Common equity shares 64049M209 999,012 74,751 8.09 8,953 22.90 0.0008
2017-05-15 2017-03-31 13F NEOGENOMICS Common equity shares 64049M209 924,261 9,188 1.00 7,285 -7.10 0.0006
2017-02-09 2016-12-31 13F NEOGENOMICS Common equity shares 64049M209 915,073 36,540 4.16 7,842 8.58 0.0007
2017-01-13 2016-09-30 13F/A-1 NEOGENOMICS Common equity shares 64049M209 878,533 20,531 2.39 7,222 4.68 0.0007
2016-11-14 2016-09-30 13F NEOGENOMICS Common equity shares 64049M209 878,533 7,222
2016-08-12 2016-06-30 13F NEOGENOMICS Common equity shares 64049M209 858,002 80,443 10.35 6,899 31.64 0.0007
2016-05-20 2016-03-31 13F/A-1 NEOGENOMICS Common equity shares 64049M209 777,559 7,266 0.94 5,241 -13.53 0.0006
2016-05-12 2016-03-31 13F NEOGENOMICS Common equity shares 64049M209 777,559 5,241
2016-02-16 2015-12-31 13F NEOGENOMICS Common equity shares 64049M209 770,293 127,357 19.81 6,061 64.57 0.0007
2015-11-16 2015-09-30 13F NEOGENOMICS Common equity shares 64049M209 642,936 208,178 47.88 3,683 56.72 0.0004
2015-08-13 2015-06-30 13F NEOGENOMICS Common equity shares 64049M209 434,758 413,758 1,970.28 2,350 2,297.96 0.0003
2015-05-15 2015-03-31 13F NEOGENOMICS Common equity shares 64049M209 21,000 0 0.00 98 11.36 0.0000
2015-02-11 2014-12-31 13F NEOGENOMICS Common equity shares 64049M209 21,000 -2,300 -9.87 88 -27.27 0.0000
2014-11-12 2014-09-30 13F/A-1 NEOGENOMICS Common equity shares 64049M209 23,300 1,600 7.37 121 68.06 0.0000
2014-11-10 2014-09-30 13F NEOGENOMICS Common equity shares 64049M209 23,300 121
2014-08-12 2014-06-30 13F NEOGENOMICS Common equity shares 64049M209 21,700 -361,623 -94.34 72 -94.59 0.0000
2014-05-15 2014-03-31 13F/A-1 NEOGENOMICS Common equity shares 64049M209 383,323 100,585 35.58 1,330 29.88 0.0002
2014-05-13 2014-03-31 13F NEOGENOMICS Common equity shares 64049M209 383,730 1,331
2014-02-06 2013-12-31 13F/A-1 NEOGENOMICS Common equity shares 64049M209 282,738 57,657 25.62 1,024 51.48 0.0001
2014-02-06 2013-12-31 13F NEOGENOMICS Common equity shares 64049M209 35,100 87
2013-11-12 2013-09-30 13F NEOGENOMICS Common equity shares 64049M209 225,081 122,581 119.59 676 65.69 0.0001
2013-08-08 2013-06-30 13F NEOGENOMICS Common equity shares 64049M209 102,500 102,500 408 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.